| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SCLX | Common Stock | Options Exercise | $8.46K | +6K | +1.97% | $1.41 | 311K | Jun 18, 2024 | Direct | F1 |
| holding | SCLX | Common Stock | 50.1K | Jun 18, 2024 | By BioVintage, Inc. | ||||||
| holding | SCLX | Common Stock | 2.75K | Jun 18, 2024 | By BioVintage, Inc. | F2, F3 | |||||
| holding | SCLX | Common Stock | 292K | Jun 18, 2024 | See Footnote | F4 | |||||
| holding | SCLX | Common Stock | 5.64K | Jun 18, 2024 | By Spouse |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SCLX | Nonstatutory Stock Option (right to buy) | Options Exercise | $0 | -6K | -3% | $0.00 | 194K | Jun 18, 2024 | Common Stock | 6K | $1.41 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | 1/48th of the number of shares subject to the option vested and shall vest on a monthly basis following the grant date, which was October 4, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date. |
| F2 | On December 30, 2022, the Board of Directors of Sorrento Therapeutics, Inc. ("Sorrento") declared a stock dividend (the "Dividend") to all holders of record of its common stock as of the close of business on January 9, 2023, of 0.1410127 of a share of Common Stock for each one share of common stock, par value $0.0001 per share, of Sorrento ("Sorrento Common Stock"). The Reporting Person wrote a put option in Sorrento Common Stock on August 26, 2022 (the "Put Option"), which was adjusted as a result of the Stock Dividend to relate to an aggregate of 19,500 shares of Sorrento Common Stock and 2,749 shares of Common Stock and to reflect a corresponding change to the exercise price of the Put Option to $0.80268 per share of Sorrento Common Stock and $8.6002 per share of Common Stock. |
| F3 | (Continued from footnote 2) The Put Option settled on March 17, 2023 and resulted in the Reporting Person becoming entitled to receive 2,749 shares of Common Stock at a price of $8.6002 per share of Common Stock, upon the expiration of the lock-up on such shares which is currently set to expire on September 30, 2024. |
| F4 | Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse. |